Senate Targets Head of American Psychiatric Association

From: http://www.paloaltoonline.com/news/show_story.php?id=8498

Palo Alto Online News

Stanford psychiatrist target of U.S. Senate inquiry  

 

Alan Schatzberg, chairman of the Psychiatry Department at Stanford Medical School and president-elect of the American Psychiatric Association, is the target of a congressional inquiry of his income from drug companies, according to U.S. News & World Report.

 

Physicians often receive income from pharmaceutical companies, which they then report to their universities.

 

But the Senate Finance Committee, led by Sen. Charles Grassley of Iowa, the ranking Republican member, found an alleged $70,000 discrepancy between the drug company income Schatzberg reported to Stanford and what he received from the companies.

 

Grassley also questioned the rigor of Stanford’s income-reporting guidelines, noting that faculty only have to report “more than $100,000 worth of stock ownership,” while Schatzberg owns $6 million of stock in company called Corcept.

 

“Obviously, $6 million is a dramatically higher number than $100,000,” Grassley said in the Senate on Monday, according to the magazine.

 

“We believe that Dr. Alan Schatzberg … has fully complied with the university’s rigorous conflict-of-interest policy,” the university said in a statement to the magazine.

 

Any discrepancies were likely “misunderstandings” due to “differences in record keeping,” according to Stanford. The university was also aware of the amount of Corcept stock Schatzberg owns.

 

— Don Kazak

One response to this post.

  1. Posted by Lissakrhumanelife on January 4, 2013 at 6:13 pm

    Reblogged this on USA COINTELPRO VICTIM OF THE CIA PATRIOT & SPACE ACTS and commented:
    Senate Targets Head of American Psychiatric Association
    Posted June 28, 2008 by Philip in Blogroll. Leave a Comment
    From: http://www.paloaltoonline.com/news/show_story.php?id=8498
    Palo Alto Online News
    Stanford psychiatrist target of U.S. Senate inquiry

    Alan Schatzberg, chairman of the Psychiatry Department at Stanford Medical School and president-elect of the American Psychiatric Association, is the target of a congressional inquiry of his income from drug companies, according to U.S. News & World Report.

    Physicians often receive income from pharmaceutical companies, which they then report to their universities.

    But the Senate Finance Committee, led by Sen. Charles Grassley of Iowa, the ranking Republican member, found an alleged $70,000 discrepancy between the drug company income Schatzberg reported to Stanford and what he received from the companies.

    Grassley also questioned the rigor of Stanford’s income-reporting guidelines, noting that faculty only have to report “more than $100,000 worth of stock ownership,” while Schatzberg owns $6 million of stock in company called Corcept.

    “Obviously, $6 million is a dramatically higher number than $100,000,” Grassley said in the Senate on Monday, according to the magazine.

    “We believe that Dr. Alan Schatzberg … has fully complied with the university’s rigorous conflict-of-interest policy,” the university said in a statement to the magazine.

    Any discrepancies were likely “misunderstandings” due to “differences in record keeping,” according to Stanford. The university was also aware of the amount of Corcept stock Schatzberg owns.

    Reply

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: